A randomized study, comparing fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) single inhaler triple therapy, versus multiple inhaler therapy (budesonide/formoterol plus tiotropium) in subjects with chronic obstructive pulmonary disease (COPD), Trial ID 207608

A randomized study, comparing fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) single inhaler triple therapy, versus multiple inhaler therapy (budesonide/formoterol plus tiotropium) in subjects with chronic obstructive pulmonary disease (COPD), Trial ID 207608 | GSK